GTR Home > Tests > Search results - STK11[gene]

Apply filters

Showing tests for all 1945 conditions

Compare labs

Your search term can be found in tests with a total of 1945 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states
More locations

GTR test search results for 6794[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 115 tests for 1945 conditions in 36 labs

CFoundationOne®

Lab: Foundation Medicine, Inc. Cambridge, Massachusetts, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total targets (315)

CSolid Tumor Panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (40)
Total targets (62)

CCancer Hotspot Panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • E Sequence analysis of select exons
Total conditions (46)
Total targets (88)

CCentoBreast (hereditary breast cancer) panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (13)

CGuardant360

Lab: Guardant Health Redwood City, California, United States
Conditions
Test targets
Methods
  • E Sequence analysis of select exons
Total targets (68)

CPancreatic cancer, somatic

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTesticular tumor, somatic

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CFoundationOne® Heme

Lab: Foundation Medicine, Inc. Cambridge, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • R RNA analysis
  • E Sequence analysis of select exons
Total targets (670)

CRapid microarray (CGH and SNP)

Lab: Allele Diagnostics Spokane, Washington, United States
Test targets
Methods
  • H Detection of homozygosity
  • D Deletion/duplication analysis
  • H Detection of homozygosity
Total conditions (247)
Total targets (231)

CPeutz-Jeghers syndrome

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CBreast ovarian cancer panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (14)

CHereditary Gastric Cancer Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (20)

CHigh Risk Breast Cancer: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (6)

CColorectal Cancer NextGen Sequencing (NGS) And Deletion/Duplication Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (21)
Total targets (17)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CSTK11. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CSTK11. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CPancreatic Cancer NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (13)
Total targets (12)

CCancer NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (43)
Total targets (35)

CPeutz-Jeghers Syndrome (STK11) Sequencing

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 115 tests for 1945 conditions in 36 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.